Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5196547
Max Phase: Preclinical
Molecular Formula: C26H20N4O2
Molecular Weight: 420.47
Associated Items:
ID: ALA5196547
Max Phase: Preclinical
Molecular Formula: C26H20N4O2
Molecular Weight: 420.47
Associated Items:
Canonical SMILES: COC(=O)c1ccc(-c2nc(Cc3c[nH]c4ccccc34)nnc2-c2ccccc2)cc1
Standard InChI: InChI=1S/C26H20N4O2/c1-32-26(31)19-13-11-18(12-14-19)24-25(17-7-3-2-4-8-17)30-29-23(28-24)15-20-16-27-22-10-6-5-9-21(20)22/h2-14,16,27H,15H2,1H3
Standard InChI Key: SCBNOILCEWFLFJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 420.47 | Molecular Weight (Monoisotopic): 420.1586 | AlogP: 5.06 | #Rotatable Bonds: 5 |
Polar Surface Area: 80.76 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 1.06 | CX LogP: 5.49 | CX LogD: 5.49 |
Aromatic Rings: 5 | Heavy Atoms: 32 | QED Weighted: 0.40 | Np Likeness Score: -0.61 |
1. Mahindra A, Jenkins L, Marsango S, Huggett M, Huggett M, Robinson L, Gillespie J, Rajamanickam M, Morrison A, McElroy S, Tikhonova IG, Milligan G, Jamieson AG.. (2022) Investigating the Structure-Activity Relationship of 1,2,4-Triazine G-Protein-Coupled Receptor 84 (GPR84) Antagonists., 65 (16.0): [PMID:35948061] [10.1021/acs.jmedchem.2c00804] |
Source(1):